These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

134 related articles for article (PubMed ID: 33707790)

  • 41. Subclinical Interstitial Lung Disease in Patients with Systemic Sclerosis. A Pilot Study on the Role of Ultrasound.
    Reyes-Long S; Gutierrez M; Clavijo-Cornejo D; Alfaro-Rodríguez A; González-Sámano K; Cortes-Altamirano JL; Muñoz-Louis R; Cruz-Arenas E; Camargo K; Gonzalez F; Bertolazzi C
    Reumatol Clin (Engl Ed); 2021 Mar; 17(3):144-149. PubMed ID: 31400981
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Assessment of modified Rodnan skin score and esophageal manometry in systemic sclerosis: a study correlating severity of skin and esophageal involvement by objective measures.
    Arif T; Adil M; Singh Sodhi J; Hassan I
    Acta Dermatovenerol Alp Pannonica Adriat; 2018 Dec; 27(4):169-173. PubMed ID: 30564828
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Ventricular late potentials in systemic sclerosis: relationship with skin involvement.
    Paradiso M; Di Franco M; Musca A; Basili S; Riccieri V; Paoletti V; De Matteis A; Mammarella A
    J Rheumatol; 2002 Jul; 29(7):1388-92. PubMed ID: 12136893
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Spleen elastography in patients with Systemic sclerosis.
    Karalilova R; Doykova K; Batalov Z; Doykov D; Batalov A
    Rheumatol Int; 2021 Mar; 41(3):633-641. PubMed ID: 33495915
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Efficacy and safety of mesenchymal stem cells in the treatment of systemic sclerosis: a systematic review and meta-analysis.
    Cui J; Jin L; Ding M; He J; Yang L; Cui S; Wang X; Ma J; Liu A
    Stem Cell Res Ther; 2022 Mar; 13(1):118. PubMed ID: 35313985
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Skin sclerosis is only of limited value to identify SSc patients with severe manifestations--an analysis of a distinct patient subgroup of the German Systemic Sclerosis Network (DNSS) Register.
    Hanitsch LG; Burmester GR; Witt C; Hunzelmann N; Genth E; Krieg T; Lehmacher W; Melchers I; Meurer M; Müller-Ladner U; Schulze-Lohoff E; Becker M; Sunderkoetter C; ; Riemekasten G
    Rheumatology (Oxford); 2009 Jan; 48(1):70-3. PubMed ID: 19056798
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Correlations between nailfold microvascular damage and skin involvement in systemic sclerosis patients.
    Ruaro B; Pizzorni C; Paolino S; Smith V; Ghio M; Casabella A; Alessandri E; Patané M; Sulli A; Cutolo M
    Microvasc Res; 2019 Sep; 125():103874. PubMed ID: 30974112
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Serum periostin levels are correlated with progressive skin sclerosis in patients with systemic sclerosis.
    Yamaguchi Y; Ono J; Masuoka M; Ohta S; Izuhara K; Ikezawa Z; Aihara M; Takahashi K
    Br J Dermatol; 2013 Apr; 168(4):717-25. PubMed ID: 23110679
    [TBL] [Abstract][Full Text] [Related]  

  • 49. History of skin thickness assessment and the Rodnan skin thickness scoring method in systemic sclerosis.
    Medsger TA; Benedek TG
    J Scleroderma Relat Disord; 2019 Jun; 4(2):83-88. PubMed ID: 35382394
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Correlation of articular involvement, skin disfigurement and unemployment with depressive symptoms in patients with systemic sclerosis: a hospital sample.
    Tedeschini E; Pingani L; Simoni E; Ferrari D; Giubbarelli C; Giuggioli D; Lumetti F; Rigatelli M; Ferri C; Ferrari S
    Int J Rheum Dis; 2014 Feb; 17(2):186-94. PubMed ID: 24576274
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Serum Soluble CD163 and its association with various disease parameters in patients with systemic sclerosis.
    Hassan WA; Baraka EA; Elnady BM; Gouda TM; Fouad N
    Eur J Rheumatol; 2016 Sep; 3(3):95-100. PubMed ID: 27733938
    [TBL] [Abstract][Full Text] [Related]  

  • 52. The fibrotic phenotype of systemic sclerosis fibroblasts varies with disease duration and severity of skin involvement: reconstitution of skin fibrosis development using a tissue engineering approach.
    Corriveau MP; Boufaied I; Lessard J; Chabaud S; Senécal JL; Grodzicky T; Chartier S; Raymond Y; Moulin VJ
    J Pathol; 2009 Mar; 217(4):534-42. PubMed ID: 19086038
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Sidestream Dark Field (SDF) imaging of oral microcirculation in the assessment of systemic sclerosis.
    Sha M; Griffin M; Denton CP; Butler PE
    Microvasc Res; 2019 Nov; 126():103890. PubMed ID: 31271765
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Characterization of Venezuelan patients with systemic sclerosis: a study in a tertiary hospital in Caracas.
    Rivas-Vargas D; Snih SA; Rodríguez MA
    Reumatol Clin (Engl Ed); 2021 Dec; 17(10):601-606. PubMed ID: 34823828
    [TBL] [Abstract][Full Text] [Related]  

  • 55. The relationship between left ventricular deformation and heart rate variability in patients with systemic sclerosis: Two- and three-dimensional strain analysis.
    Tadic M; Zlatanovic M; Cuspidi C; Ivanovic B; Stevanovic A; Damjanov N; Kocijancic V; Celic V
    Int J Cardiol; 2017 Jun; 236():145-150. PubMed ID: 28222894
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Clinical and laboratory predictions of myocardial inflammation as detected by cardiac magnetic resonance imaging in patients with systemic sclerosis: A pilot study.
    Tipparot T; Foocharoen C; Mahakkanukrauh A; Suwannaroj S; Nanagara R; Pussadhamma B; Chaosuwannakit N
    Int J Rheum Dis; 2019 Dec; 22(12):2125-2133. PubMed ID: 31659856
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Possible association of elevated serum collagen type IV level with skin sclerosis in systemic sclerosis.
    Motegi SI; Sekiguchi A; Fujiwara C; Toki S; Ishikawa O
    J Dermatol; 2017 Feb; 44(2):167-172. PubMed ID: 27568491
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Validation of the suction device Nimble for the assessment of skin fibrosis in systemic sclerosis.
    Müller B; Ruby L; Jordan S; Rominger MB; Mazza E; Distler O
    Arthritis Res Ther; 2020 Jun; 22(1):128. PubMed ID: 32493508
    [TBL] [Abstract][Full Text] [Related]  

  • 59. COMP: a candidate molecule in the pathogenesis of systemic sclerosis with a potential as a disease marker.
    Hesselstrand R; Kassner A; Heinegård D; Saxne T
    Ann Rheum Dis; 2008 Sep; 67(9):1242-8. PubMed ID: 18065498
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Toll-like receptor 9 in systemic sclerosis patients: relation to modified Rodnan skin score, disease severity, and functional status.
    Gheita TA; Sayed S; Azkalany GS; Abaza N; Hammam N; Eissa AH
    Clin Rheumatol; 2018 Mar; 37(3):757-763. PubMed ID: 29076114
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.